1066184

Alexion Pharmaceuticals, Inc. — FEI 3006031727

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 10, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New Haven, CT (United States)

Additional Details

Sponsor, Contract Research Organization